Perspective Therapeutics, Inc. — Director's Dealing 2014

May 27, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2014-05-21

Reporting Person: Babcock Dwight William (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-21	Stock Option	$2.17	A	50000	Acquired	2024-05-20	Common Stock (50000)	Direct

Footnotes

F1: (right to buy)